Abstract
The vertigo symptom in breast cancer survivors has rarely been mentioned. The aim of this study was to investigate the causes of vertigo in breast cancer survivors with vertigo. From May 1997 to April 2003, 36 consecutive female breast cancer survivors with vertigo underwent a battery of tests including physical examination, neurological examination, serum lipid profile, plain chest radiograph, whole body bone scan, liver sonography, audiometry, electronystagmography (ENG) and MRI scan. Based on these tests, the causes of vertigo were attributed to peripheral labyrinthine origin in 14 patients (39%) and central origin in 22 patients (61%) consisting of 11 cases of vascular insufficiency, eight of hyperlipidemia and three of posterior fossa metastases (8%). The latter included one case of cerebellopontine angle and two of cerebellum, accompanied by extracranial systemic metastases, e.g., of the lung, bone or liver. In conclusion, vertigo in breast cancer survivors warrants concern, especially in those with extra-cranial systemic metastasis accompanied by headache. In addition to 8% occurrence of posterior fossa metastasis, other possible causes for vertigo in breast cancer survivors consist of vascular insufficiency, hyperlipidemia and labyrinthine lesion.
Similar content being viewed by others
References
Boogerd W, Vos VW, Hart AAM, Baris G (1993) Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurol-Oncol 15:165–174
Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705
Graf AH, Buchberger W, Langmayr H, Schmid KW (1988) Site preference of metastatic tumors of the brain. Virchows Arch Pathol Anat Histopathol 412:493–498
Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226
Streitmann MJ, Sismanis A (1996) Metastatic carcinoma of the temporal bone. Am J Otol 17:780–783
Wronski M, Arbit E, McCormick B (1997) Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80:1746–1754
Huang TW, Young Y-H (2002) Differentiation of cerebellopontine angle tumors in cancer patients. Otol Neurotol 23:975–979
Gloria-Cruz TI, Schachern PA, Paparella MM, Adams GL, Fulton SE (2000) Metastases to temporal bones from primary nonsystematic malignant neoplasms. Arch Otolaryngol Head Neck Surg 126:209–214
Kiricuta IC, Kolbl O, Willner J, Bohndorf W (1992) Central nervous system metastases in breast cancer. J Cancer Res Clin Oncol 118:542–546
Viadana E, Bross ID, Pickren JW (1973) An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27:336–340
Zee DS (1984) New concept of cerebellar control of eye movements. Otolaryngol Head Neck Surg 92:59–62
Alexopoulos CG, Blatsios B, Avgerinos A (1987) Serum lipids and lipoprotein disorders in cancer patients. Cancer 60:3065–3070
De Waard F (1975) Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351–3356
Miller AB, Kelly A, Choi NW, Matthews V, Morgan RW, Munan L, Burch JD, Feather J, Howe GR, Jain M (1978) A study of diet and breast cancer. Am J Epidemiol 107:499–509
Rossner S, Wallgren A (1984) Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis 52:339–346
Glueck CJ, Fallat RW, Schell D (1975) Effects of estrogenic compounds on triglyceride kinetics. Metabolism 24:537–545
Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, Hazzard WR (1977) Effect of estrogen on post-heparin lipolytic activity: selective decline in hepatic triglyceride lipase. J Clin Invest 59:601–608
Brun LD, Gagne C, Rousseau C, Moorjani S, Lupien PJ (1986) Severe lipemia induced by tamoxifen. Cancer 57:2123–2126
Kanel KT, Thompson PD (1997) Delayed severe hypertriglyceridemia from tamoxifen. New Engl J Med 337:281–282
Joensuu H, Holli K, Oksanen H, Valavaara R (2000) Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer. Breast Cancer Res Tr 63:225–234
Acknowledgements
This study was made possible by grant no. NSC 92-2314-B002-349 from the National Science Council, Taipei, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, ZM., Young, YH. Investigating the causes of vertigo in breast cancer survivors. Eur Arch Otorhinolaryngol 262, 432–436 (2005). https://doi.org/10.1007/s00405-004-0846-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0846-5